These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 96666
1. Inhibitors of beta-glucosidases of animal tissues. Radin NS. Adv Exp Med Biol; 1978; 101():589-600. PubMed ID: 96666 [No Abstract] [Full Text] [Related]
2. Glyconamides as inhibitors of human beta-glucosidases and beta-galactosidases. Chiao YB, Moffitt K, Smallwood Y, Glew RH, Naoi M, Lee YC. Arch Biochem Biophys; 1979 Jan; 192(1):1-9. PubMed ID: 107857 [No Abstract] [Full Text] [Related]
3. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites. Osiecki-Newman K, Fabbro D, Legler G, Desnick RJ, Grabowski GA. Biochim Biophys Acta; 1987 Sep 02; 915(1):87-100. PubMed ID: 2956992 [Abstract] [Full Text] [Related]
7. [Beta-glucosidases. Molecular bases of Gaucher's disease]. Maret A, Salvayre R, Negre A, Douste-Blazy L. Pathol Biol (Paris); 1985 Jun 27; 33(6):693-713. PubMed ID: 3931039 [Abstract] [Full Text] [Related]
8. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Peters SP, Coyle P, Glew RH. Arch Biochem Biophys; 1976 Aug 27; 175(2):569-82. PubMed ID: 958319 [No Abstract] [Full Text] [Related]
9. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase. Gatt S, Dinur T, Osiecki K, Desnick RJ, Grabowski GA. Enzyme; 1985 Aug 27; 33(2):109-19. PubMed ID: 3924590 [Abstract] [Full Text] [Related]
11. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease. Gatt S, Dinur T, Desnick RJ. Prog Clin Biol Res; 1982 Aug 27; 95():315-31. PubMed ID: 6812076 [No Abstract] [Full Text] [Related]
12. Multiple forms of beta-glucosidase in Gaucher disease. Yaqoob M, Carroll M. Prog Clin Biol Res; 1982 Aug 27; 95():453-63. PubMed ID: 6812081 [No Abstract] [Full Text] [Related]
13. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase. Prence EM, Garrett KO, Panitch H, Basu A, Glew RH, Wherrett JR, Huterer S. Clin Chim Acta; 1986 Apr 30; 156(2):179-89. PubMed ID: 3085988 [Abstract] [Full Text] [Related]
14. Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases. Gopalan V, Daniels LB, Glew RH, Claeyssens M. Biochem J; 1989 Sep 01; 262(2):541-8. PubMed ID: 2508630 [Abstract] [Full Text] [Related]
15. Comparative properties of the three groups of splenic beta-glucosidase molecular forms. Salvayre R, Maret A, Negre A, Douste-Blazy L. Prog Clin Biol Res; 1982 Sep 01; 95():443-52. PubMed ID: 6812080 [No Abstract] [Full Text] [Related]